Ascend aims for 2% to 3% Q2 growth
Ascend Wellness Holdings outlined its Q2 growth expectations. The company is targeting 2% to 3% top line growth.
The growth target comes as the company explores pathways to uplist.
The US Department of Justice recently rescheduled medical cannabis from Schedule I to Schedule III, which may impact the company’s operations.